4.15
price up icon3.49%   0.14
after-market Handel nachbörslich: 4.30 0.15 +3.61%
loading

Finanzdaten der Diamedica Therapeutics Inc-Aktie (DMAC)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
0.03%
3.676
3.677 3.272 2.543 3.618
Operating Income/Loss
1.83%
-5.741
-5.848 -5.157 -4.741 -5.521
Income/Loss From Continuing Operations Before Tax
0.10%
-5.144
-5.139 -4.464 -4.47 -5.265
Income Tax Expense/Benefit
68.18%
0.007
0.022 0.007 0.007 0.007
Income/Loss From Continuing Operations After Tax
0.19%
-5.151
-5.161 -4.471 -4.477 -5.272
Net Income/Loss
0.19%
-5.151
-5.161 -4.471 -4.477 -5.272
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,991%
37.96
1.8154 37.95 27.31 26.45
Basic Earnings Per Share
0.00%
-0.14
-0.14 -0.12 -0.16 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Kapitalisierung:     |  Volumen (24h):